Whalesbook
Record Backlog Outshines Current Quarter Weakness
Cyient DLM Ltd. reported its fourth-quarter financial results for the period ending March 31, 2026. Net profit decreased by 27.7% year-on-year to ₹22.4 crore, with revenue contracting 13.8% to ₹369 crore from ₹428 crore in the same quarter last year. EBITDA also slid 25% to ₹42.9 crore, and EBITDA margins narrowed to 11.6% from 13.4% year-on-year. Despite these figures, the company's closing order book reached ₹2,416.6 crore, a decade high. This substantial backlog, coupled with a book-to-bill ratio consistently above one across all quarters, signals strong demand and future revenue growth potential. The market reacted positively, with the stock closing up 4.24% at ₹360.20 on April 21, 2026, indicating investor focus on forward-looking indicators over current quarterly performance.
Navigating Segmental Shifts and Sector Tailwinds
The company's defense segment saw a significant 68% year-on-year decline in Q4 FY26, largely due to the completion of major aerospace and defense contracts. This highlights the variable nature of defense revenues, though analysts believe this phase may be ending, with growth expected to resume. Aerospace remains the dominant revenue segment. Printed Circuit Board Assemblies (PCBA) continued to be a key product, making up 48% of revenue, while box build revenue grew 17% year-on-year. International markets, especially from aerospace, medical, and industrial clients, are driving growth, with India contributing a smaller 8%. Diversifying into medical and industrial sectors alongside aerospace is crucial for more consistent order inflows.
The Bear Case: Order Cyclicality and Margin Pressures
While the record order book offers a strong buffer, the company's reliance on large, cyclical defense contracts has historically caused revenue volatility, as seen in the Q4 FY26 defense segment drop. Analysts noted that revenue missed Q3 FY26 estimates, though order wins provided some comfort. Profitability also faced pressure, with EBITDA margins declining to 11.6% from 13.4% year-on-year. This could be due to a less favorable business mix or increased operating expenses, including those from its US activities and specific service lines. The company reported one-time items impacting FY26, such as an earnout reversal, wage code adjustments, and M&A expenses. These, while not recurring, can affect underlying operational performance. Cyient DLM maintains a healthy debt-to-equity ratio of 21.4% and sufficient cash reserves. Its P/E ratio of approximately 33.1x is considered high compared to the Indian electronic industry average, though it trades at a discount to its peers.
Future Outlook and Analyst Consensus
Analysts hold a cautiously optimistic view, with consensus suggesting the "worst appears to be behind" for Cyient DLM and growth is expected to resume from Q4 FY26. The average analyst target price is ₹469.67, representing a potential upside of over 30% from the current stock price, with most recommendations leaning towards 'Accumulate' or 'Buy'. The company's strategy includes expanding its manufacturing footprint, possibly via acquisitions in North America and EMEA, and diversifying into medical and industrial sectors. Successfully executing these plans is key for Cyient DLM to capitalize on the strong growth potential within the expanding Indian EMS and Aerospace & Defence industries.